{"id":68994,"date":"2026-03-12T15:22:39","date_gmt":"2026-03-12T15:22:39","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68994"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"cjc-1295-with-dac","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/cjc-1295-with-dac\/","title":{"rendered":"CJC-1295 cu DAC"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u0103spuns rapid \u2014 Ce este CJC-1295 cu DAC?<\/h3>\n<p style=\"margin: 0;\"><strong>CJC-1295 cu DAC<\/strong> este un analog sintetic al hormonului de eliberare a hormonului de cre\u0219tere (GHRH 1-29) modificat cu un <strong>Complex de Afinitate pentru Medicament (DAC)<\/strong> care se leag\u0103 covalent de albumina plasmatic\u0103. Legarea de albumin\u0103 prelunge\u0219te timpul de \u00eenjum\u0103t\u0103\u021bire plasmatic de la ~30 de minute la aproximativ 7 zile, permi\u021b\u00e2nd dozarea s\u0103pt\u0103m\u00e2nal\u0103 sau de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103 \u00een cercetare. Este furnizat \u00een vile de 2 mg \u0219i 5 mg liofilizate, exclusiv pentru uz \u00een cercetare de laborator.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Peptide liofilizate pentru cercetare \u00b7 puritate HPLC \u226599% (certificat de analiz\u0103 la cerere) \u00b7 Ambalaj discret stabil la temperatur\u0103 \u00b7 Curierat worldwide de peptide \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifica\u021bii<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detaliu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u0103r CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">863288-34-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>165<\/sub>H<sub>269<\/sub>N<sub>47<\/sub>O<sub>46<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Greutate molecular\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3647.25 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secven\u021b\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-Tyr-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-NH<sub>2<\/sub> conjugat cu maleimidopropionil-Lys (leg\u0103tur\u0103 DAC pentru legarea albuminei)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form\u0103<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pulbere liofilizat\u0103 (sau a\u0219a cum este furnizat)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puritate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificat prin HPLC, COA la cerere)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Depozitare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizat: 2\u20138\u00b0C (frigider) pentru stocul de lucru; \u221220\u00b0C pentru depozitarea pe termen lung a vialelor nefolosite. Reconstituit: 2\u20138\u00b0C, utilizat \u00een ~30 de zile. Proteja\u021bi de lumin\u0103. Nu \u00eenghe\u021ba\u021bi-decongela\u021bi solu\u021bia reconstituit\u0103.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilitate<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ap\u0103 bacteriostatic\u0103 (recomandat\u0103) sau ap\u0103 steril\u0103 pentru perioade mai scurte de utilizare<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Utilizare \u00een cercetare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Doar pentru utilizare \u00een cercetare de laborator. Nu este destinat pentru uz diagnostic sau terapeutic uman sau veterinar.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Ce este CJC-1295 cu DAC?<\/h2>\n<p><strong>CJC-1295<\/strong> este un analog sintetic de 30 de aminoacizi al hormonului de eliberare a hormonului de cre\u0219tere (GHRH), mai exact o form\u0103 modificat\u0103 a fragmentului biologic activ GHRH (1-29). Sufixul \u201c<strong>with DAC<\/strong>\u201d sufixul se refer\u0103 la un produs proprietar <strong>Complex de Afinitate pentru Medicament (DAC)<\/strong> \u2014 un reziduu de acid maleimidopropionic ata\u0219at la lizina-30 \u2014 care formeaz\u0103 o leg\u0103tur\u0103 covalent\u0103 cu cisteina-34 din serul albuminic <em>in vivo<\/em>.<\/p>\n<p>Aceast\u0103 leg\u0103tur\u0103 cu albumina este inova\u021bia cheie. GHRH-ul natural are o semi-via\u021b\u0103 plasmatic\u0103 m\u0103surat\u0103 \u00een minute (degradare rapid\u0103 prin DPP-IV); CJC-1295 cu DAC circul\u0103 legat de albumin\u0103 timp de aproximativ <strong>7 zile<\/strong>, permi\u021b\u00e2nd dozarea de cercetare s\u0103pt\u0103m\u00e2nal\u0103 sau de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103, men\u021bin\u00e2nd \u00een acela\u0219i timp nivelurile ridicate de GH\/IGF-1 \u00eentre injec\u021bii. Acesta este un profil farmacocinetic fundamental diferit de versiunea \u201cf\u0103r\u0103 DAC\u201d (uneori numit\u0103 Mod GRF 1-29), care p\u0103streaz\u0103 semi-via\u021ba scurt\u0103 a GHRH-ului natural. Dezvoltat de ConjuChem, CJC-1295 este <strong>destinat doar pentru cercetare de laborator<\/strong> \u0219i nu este destinat pentru diagnostic sau terapie uman\u0103 sau veterinar\u0103. Pentru mecanism, context de cercetare \u0219i protocoale de stivuire, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 research guide<\/a>.<\/p>\n<h2>Mecanismul de Ac\u021biune \u2014 Agonism GHRH cu Eliberare Prelungit\u0103<\/h2>\n<p>CJC-1295 cu DAC ac\u021bioneaz\u0103 prin dou\u0103 mecanisme secven\u021biale:<\/p>\n<ul>\n<li><strong>agonismul receptorului GHRH<\/strong> \u2014 peptidul se leag\u0103 de receptorii GHRH de pe somatotrofiile hipofizare, stimul\u00e2nd sinteza \u0219i eliberarea hormonului de cre\u0219tere. Acesta este acela\u0219i receptor \u0219i cale de semnalizare ca \u0219i GHRH-ul endogen.<\/li>\n<li><strong>Albumin-legat cu prelungirea timpului de \u00eenjum\u0103t\u0103\u021bire<\/strong> \u2014 lan\u021bul lateral DAC de lizin\u0103 formeaz\u0103 o leg\u0103tur\u0103 covalent\u0103 de tip Michael-addition cu tiolul liber de pe cisteina-34 a albuminei. Timpul de \u00eenjum\u0103t\u0103\u021bire de ~20 de zile al albuminei transport\u0103 peptidul \u00eempreun\u0103 cu ea, protej\u00e2nd CJC-1295 de clivarea rapid\u0103 de c\u0103tre DPP-IV \u0219i prelungind timpul de \u00eenjum\u0103t\u0103\u021bire func\u021bional \u00een plasm\u0103 la ~7 zile. Rezultatul este o expunere sus\u021binut\u0103 a celulelor hipofizare la semnalul GHRH, \u00een locul pulsuriilor scurte observate cu GHRH nativ.<\/li>\n<li><strong>Amplificarea IGF-1 hepatic<\/strong> \u2014 expunerea crescut\u0103 \u0219i sus\u021binut\u0103 la GH stimuleaz\u0103 produc\u021bia hepatic\u0103 de IGF-1. Cineticile de eliberare prelungit\u0103 \u00eenseamn\u0103 c\u0103 nivelurile de IGF-1 r\u0103m\u00e2n ridicate pe tot parcursul intervalului de dozare, \u00een loc s\u0103 creasc\u0103 \u0219i s\u0103 scad\u0103 \u00een c\u00e2teva ore.<\/li>\n<\/ul>\n<p>Consecin\u021ba practic\u0103 \u00een cercetare: o singur\u0103 injec\u021bie s\u0103pt\u0103m\u00e2nal\u0103 men\u021bine un ton ridicat de GH \u0219i IGF-1 pe \u00eentregul interval, elimin\u00e2nd necesitatea injec\u021biilor multiple zilnice. Atunci c\u00e2nd este combinat cu un GHRP, cum ar fi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin\/\">ipamorelin<\/a> (care ac\u021bioneaz\u0103 pe calea paralel\u0103 a receptorului ghrelin\u0103), combina\u021bia produce pulsuri de GH mai mari dec\u00e2t fiecare singur \u2014 stiva canonic\u0103 de cercetare a axei GH.<\/p>\n<h2>Aplica\u021bii de Cercetare Publicate<\/h2>\n<p>CJC-1295 cu DAC este utilizat \u00een contexte de cercetare de laborator care investigheaz\u0103:<\/p>\n<ul>\n<li><strong>Cre\u0219terea IGF-1 hepatic<\/strong> \u2014 r\u0103spunsul sus\u021binut al IGF-1 \u00een plasm\u0103 prin semnalul GHRH cu eliberare prelungit\u0103 (Teichman et al., J Clin Endocrinol Metab 2006)<\/li>\n<li><strong>Protocoale de dozare prelungit\u0103<\/strong> \u2014 protocoale de cercetare s\u0103pt\u0103m\u00e2nale sau bis\u0103pt\u0103m\u00e2nale posibile datorit\u0103 timpului de \u00eenjum\u0103t\u0103\u021bire de ~7 zile<\/li>\n<li><strong>Cercetarea compozi\u021biei corporale<\/strong> \u2014 cercet\u0103ri privind masa slab\u0103, masa gras\u0103 \u0219i compozi\u021bia corporal\u0103 \u00een studiile de modulare a axei GH<\/li>\n<li><strong>Cercetare de sinergie cu Ipamorelin<\/strong> \u2014 protocolul canonic \u201cCJC-1295 + ipamorelin\u201d investig\u00e2nd farmacologia aditiv\u0103 a GHRH + GHRP<\/li>\n<li><strong>Arhitectura somnului<\/strong> \u2014 cercetare privind somnul cu unde lente \u0219i axa GH nocturn\u0103 \u00een modele preclinice<\/li>\n<li><strong>Cercetarea densit\u0103\u021bii osoase<\/strong> \u2014 cercetare privind activitatea osteoblastelor \u0219i densitatea mineral\u0103 osoas\u0103 prin modularea axei GH\/IGF-1<\/li>\n<li><strong>Cercetare comparativ\u0103 cu GHRH<\/strong> \u2014 \u00een paralel cu <a href=\"https:\/\/medsbase.com\/ro\/sermorelin-peptide-guide\/\">sermorelin<\/a> \u0219i <a href=\"https:\/\/medsbase.com\/ro\/tesamorelin-peptide-guide\/\">tesamorelin<\/a> (ambele analoge GHRH f\u0103r\u0103 DAC) pentru a izola efectul de prelungire a timpului de \u00eenjum\u0103t\u0103\u021bire<\/li>\n<\/ul>\n<p>Pentru un context mai larg privind panorama peptidelor axei GH, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/peptides\/\">de peptide de cercetare<\/a>.<\/p>\n<h2>Concentra\u021bii \u0219i doze disponibile<\/h2>\n<p>MedsBase de\u021bine CJC-1295 cu DAC \u00een urm\u0103toarele dimensiuni de flacoane liofilizate. Fiecare variant\u0103 este livrat\u0103 \u00een pachete de 10, 20 sau 30 de flacoane:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Putere flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caz de utilizare tipic<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensiuni pachet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoale scurte, dozaj pilot \u2014 sus\u021bine ~7 administr\u0103ri s\u0103pt\u0103m\u00e2nale per flacon<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 sau 30 de flacoane<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Putere standard de cercetare \u2014 sus\u021bine ~17 administr\u0103ri s\u0103pt\u0103m\u00e2nale per flacon<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 sau 30 de flacoane<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Deoarece CJC-1295 cu DAC este de obicei administrat \u00een doze de 1\u20132 mg s\u0103pt\u0103m\u00e2nal (sau 300\u2013500 mcg bis\u0103pt\u0103m\u00e2nal), un singur flacon acoper\u0103 o perioad\u0103 \u00eendelungat\u0103 de cercetare. Toate concentra\u021biile sunt furnizate sub form\u0103 de pulbere liofilizat\u0103 cu o puritate de peste 99% confirmat\u0103 prin HPLC.<\/p>\n<h2>Compara\u021bie \u2014 CJC-1295 cu DAC vs f\u0103r\u0103 DAC vs Ipamorelin<\/h2>\n<p>Cele trei peptide cel mai frecvent studiate ale axei GH difer\u0103 semnificativ \u00een mecanism \u0219i dozare:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criteriu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 cu DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 f\u0103r\u0103 DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clasa de peptizi<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analog GHRH (modificat)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analog GHRH (Mod GRF 1-29)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (receptor de ghrelin\u0103)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Timp de \u00eenjum\u0103t\u0103\u021bire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 zile (legat de albumin\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 de minute<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 ore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Frecven\u021ba administr\u0103rii<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 ori pe s\u0103pt\u0103m\u00e2n\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20133 ori pe zi<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20133 ori pe zi<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Profil GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cre\u0219tere sus\u021binut\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulsatil, scurt<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Explozie pulsatil\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Doza tipic\u0103 de cercetare<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 mg s\u0103pt\u0103m\u00e2nal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013200 mcg pe puls<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300 mcg pe puls<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Partener canonic<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ipamorelin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ipamorelin (stiv\u0103 scurt\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">CJC-1295 (cu sau f\u0103r\u0103 DAC)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Compara\u021bia farmacologic\u0103 complet\u0103, protocoalele de stivuire \u0219i momentul \u00een care cercet\u0103torii aleg versiunile \u201ccu DAC\u201d fa\u021b\u0103 de \u201cf\u0103r\u0103 DAC\u201d sunt acoperite \u00een ghidul nostru <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">Ghidul de cercetare Ipamorelin + CJC-1295<\/a>.<\/p>\n<h2>Depozitare \u0219i reconstituire<\/h2>\n<p><strong>\u00cenainte de reconstituire:<\/strong> p\u0103stra\u021bi flacoanele liofilizate la frigider la 2\u20138\u00b0C \u00een ambalajul original, stabile p\u00e2n\u0103 la 36 de luni. Evita\u021bi ciclurile de \u00eenghe\u021b-dezghe\u021b pe pulbere.<\/p>\n<p><strong>Procedura de reconstituire:<\/strong> injecta\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului de peptide conform graficului de diluare de mai sus. \u00cenv\u00e2rti\u021bi u\u0219or \u2014 nu <strong>prime\u0219te,<\/strong> agita\u021bi u\u0219or \u0219i a\u0219tepta\u021bi 5\u201310 minute pentru dizolvare complet\u0103. Solu\u021bia reconstituit\u0103 corect ar trebui s\u0103 fie clar\u0103 \u0219i incolor\u0103.<\/p>\n<p><strong>Dup\u0103 reconstituire:<\/strong> p\u0103stra\u021bi la frigider la 2\u20138\u00b0C \u0219i folosi\u021bi \u00een termen de 30 de zile. Nu congela\u021bi solu\u021bia reconstituit\u0103 \u2014 ciclurile de \u00eenghe\u021b-dezghe\u021b degradeaz\u0103 integritatea peptidului.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>Pentru ce este utilizat CJC-1295 cu DAC \u00een cercetare?<\/h3>\n<p>CJC-1295 cu DAC este utilizat \u00een cercetarea de laborator care investigheaz\u0103 semnalizarea GHRH cu eliberare prelungit\u0103, cre\u0219terea IGF-1 hepatic, compozi\u021bia corporal\u0103, cinetica axei GH, cercetarea somnului \u0219i stivuirea sinergic\u0103 cu peptide GHRP precum ipamorelin. Este <strong>prime\u0219te,<\/strong> aprobat de FDA \u0219i este v\u00e2ndut aici strict pentru uz \u00een cercetare de laborator.<\/p>\n<h3>Ce \u00eenseamn\u0103 \u201ccu DAC\u201d?<\/h3>\n<p>DAC \u00eenseamn\u0103 <strong>Complex de Afinitate pentru Medicament<\/strong> \u2014 un reziduu de maleimidopropionic\u0103 ata\u0219at la peptid care se leag\u0103 covalent de cisteina-34 de pe serul albumin. Leg\u0103tura cu albumina prelunge\u0219te timpul de \u00eenjum\u0103t\u0103\u021bire \u00een plasm\u0103 de la ~30 de minute (GHRH nativ) la aproximativ 7 zile, permi\u021b\u00e2nd dozarea s\u0103pt\u0103m\u00e2nal\u0103 \u00een cercetare.<\/p>\n<h3>Care este diferen\u021ba dintre CJC-1295 cu DAC \u0219i f\u0103r\u0103 DAC?<\/h3>\n<p>Secven\u021ba peptidic\u0103 de baz\u0103 este aceea\u0219i. Versiunea \u201ccu DAC\u201d are ata\u0219at maleimida care se leag\u0103 de albumin\u0103, oferind un timp de \u00eenjum\u0103t\u0103\u021bire de ~7 zile \u0219i dozare s\u0103pt\u0103m\u00e2nal\u0103. Versiunea \u201cf\u0103r\u0103 DAC\u201d (numit\u0103 \u0219i Mod GRF 1-29) nu are leg\u0103tura cu albumina, are un timp de \u00eenjum\u0103t\u0103\u021bire de ~30 de minute \u0219i necesit\u0103 doze multiple zilnice. Ambele au cazuri de utilizare \u00een cercetare. Consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/cjc-1295-without-dac\/\">pagina produsului CJC-1295 f\u0103r\u0103 DAC<\/a>.<\/p>\n<h3>Care este doza tipic\u0103 de cercetare pentru CJC-1295 cu DAC?<\/h3>\n<p>Protocoalele preclinice publicate utilizeaz\u0103 de obicei 1\u20132 mg o dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 sau 300\u2013500 mcg de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103. Un flacon de 2 mg reconstituit cu 2,0 mL ap\u0103 bacteriostatic\u0103 ofer\u0103 1,0 mg\/mL \u2014 30 de diviziuni pe o sering\u0103 U-100 ofer\u0103 300 mcg.<\/p>\n<h3>Este CJC-1295 aprobat de FDA?<\/h3>\n<p>Nu. CJC-1295 a fost dezvoltat ini\u021bial de ConjuChem dar nu a primit niciodat\u0103 aprobare regulatorie de la FDA sau EMA pentru nicio indica\u021bie. Tot CJC-1295 v\u00e2ndut de furnizori pentru uz exclusiv \u00een cercetare este destinat investiga\u021biilor de laborator, nu terapiei.<\/p>\n<h3>Cum ar trebui stocat CJC-1295 cu DAC?<\/h3>\n<p>Viale liofilizate: p\u0103strate la frigider la 2\u20138 \u00b0C \u00een ambalajul original, stabile p\u00e2n\u0103 la 36 de luni. Solu\u021bie reconstituit\u0103: p\u0103strat\u0103 la frigider la 2\u20138 \u00b0C, de utilizat \u00een 30 de zile. Nu \u00eenghe\u021ba\u021bi solu\u021bia reconstituit\u0103.<\/p>\n<h3>Cum reconstitui CJC-1295 cu DAC?<\/h3>\n<p>Urma\u021bi graficul de reconstituire de mai sus. Ad\u0103uga\u021bi ap\u0103 bacteriostatic\u0103 pe peretele lateral al flaconului, amesteca\u021bi u\u0219or \u0219i l\u0103sa\u021bi 5\u201310 minute pentru dizolvare complet\u0103. Nu <strong>prime\u0219te,<\/strong> agita\u021bi flaconul.<\/p>\n<h3>Ar trebui s\u0103 combin CJC-1295 cu DAC cu ipamorelin\u0103 \u00een cercetare?<\/h3>\n<p>Perechea CJC-1295 + ipamorelin\u0103 este combina\u021bia canonic\u0103 \u00een cercetarea axei GH. Cele dou\u0103 peptide se leag\u0103 de receptori diferi\u021bi (GHRH-R vs ghrelin-R) pe acelea\u0219i celule pituitare, iar efectele lor asupra eliber\u0103rii GH sunt sinergice \u2014 utilizarea combinat\u0103 produce impulsuri GH mai mari dec\u00e2t fiecare separat. Consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\">ghidul de cercetare pentru combina\u021bii<\/a> pentru protocoale.<\/p>\n<h3>Ce doze stocheaz\u0103 MedsBase?<\/h3>\n<p>MedsBase ofer\u0103 CJC-1295 cu DAC \u00een flacoane liofilizate de 2 mg \u0219i 5 mg. Fiecare concentra\u021bie este disponibil\u0103 \u00een pachete de 10, 20 sau 30 de flacoane. Toate flacoanele sunt furnizate cu o puritate HPLC de 99%+ \u0219i un certificat de analiz\u0103 la cerere.<\/p>\n<h3>Cauzeaz\u0103 CJC-1295 cu DAC efecte adverse \u00een cercetare?<\/h3>\n<p>Cercet\u0103rile preclinice publicate au raportat un profil de siguran\u021b\u0103 rezonabil la dozele tipice de cercetare. Cel mai frecvent raportat efect este ro\u0219ea\u021ba tranzitorie la locul inject\u0103rii. Datele privind siguran\u021ba pe termen lung la om nu sunt disponibile deoarece studiile clinice au fost \u00eentrerupte. Unele studii au identificat un risc de \u201cs\u00e2ngerare GH\u201d (cre\u0219tere sus\u021binut\u0103 produc\u00e2nd satura\u021bie IGF-1) la doze foarte mari.<\/p>\n<h3>Care este timpul de \u00eenjum\u0103t\u0103\u021bire al CJC-1295 cu DAC?<\/h3>\n<p>CJC-1295 cu DAC are un timp de \u00eenjum\u0103t\u0103\u021bire de aproximativ 6\u20138 zile, ob\u021binut prin tehnologia Drug Affinity Complex (DAC) \u2014 un grup maleimidopropionic care formeaz\u0103 o leg\u0103tur\u0103 covalent\u0103 cu albumina seric\u0103 circulant\u0103. Acest lucru prelunge\u0219te dramatic intervalul de administrare; majoritatea protocoalelor de cercetare utilizeaz\u0103 administrarea s\u0103pt\u0103m\u00e2nal\u0103 sau de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103.<\/p>\n<h3>Ce \u00eenseamn\u0103 DAC \u00een CJC-1295 cu DAC?<\/h3>\n<p>DAC \u00eenseamn\u0103 Drug Affinity Complex \u2014 un grup reactiv ata\u0219at la peptid care, odat\u0103 injectat, se leag\u0103 covalent de albumina circulant\u0103 (timp de \u00eenjum\u0103t\u0103\u021bire ~19 zile), prelungind dramatic perioada de activitate a peptidului. Rezultatul este un model de eliberare continu\u0103, non-pulsatil\u0103 a GH (adesea numit \u201cs\u00e2ngerare GH\u201d), care difer\u0103 de secre\u021bia puls\u0103til\u0103 produs\u0103 de CJC-1295 f\u0103r\u0103 DAC sau de Sermorelin.<\/p>\n<h3>Pot comanda CJC-1295 cu DAC pentru transport interna\u021bional?<\/h3>\n<p>Da. MedsBase expediaz\u0103 CJC-1295 cu DAC \u00een \u00eentreaga lume prin re\u021beaua noastr\u0103 dedicat\u0103 de transport de peptide. Comenzile care con\u021bin doar peptide se calific\u0103 pentru serviciul nostru de transport independent de peptide. Comenzile sunt expediate \u00een ambalaje cu control al temperaturii \u0219i cu urm\u0103rire complet\u0103.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte peptide pentru cercetare \u00een recuperare \u0219i performan\u021b\u0103<\/h2>\n<ul>\n<li><a href=\"\/ro\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Compus de protec\u021bie corporal\u0103 \u2014 cercetare \u00een recuperarea tendonilor, ligamentelor \u0219i intestinului<\/li>\n<li><a href=\"\/ro\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment de Thymosin Beta-4 \u2014 cercetare \u00een recuperarea \u021besuturilor moi \u0219i vasculare<\/li>\n<li><a href=\"\/ro\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonist selectiv de ghrelin\u0103 \u2014 puls de hormon de cre\u0219tere f\u0103r\u0103 cortizol\/prolactin\u0103<\/li>\n<li><a href=\"\/ro\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Peptid de cupru \u2014 cercetare \u00een regenerarea pielii \u0219i a \u021besutului conjunctiv<\/li>\n<li><a href=\"\/ro\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Analog Long-R3 IGF-1 \u2014 cercetare anabolic\u0103 \/ regenerativ\u0103<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lectur\u0103 suplimentar\u0103<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Afla\u021bi cercetarea din spatele acestui peptid<\/strong><\/p>\n<p style=\"margin: 0;\">Cititi ghidul nostru complet bazat pe dovezi: <a href=\"https:\/\/medsbase.com\/ro\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 mecanism, combinare \u0219i protocoale<\/strong><\/a>. Acoper\u0103 farmacologia GHRH vs GHRP, logica din spatele stivei canonice, protocoalele de dozare publicate, reconstituirea \u0219i notele de siguran\u021b\u0103.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sus\u021bine semnalizarea de cre\u0219tere<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te reglarea metabolic\u0103<br \/>\n\u2705 Promoveaz\u0103 regenerarea \u021besuturilor<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te c\u0103ile de recuperare<br \/>\n\u2705 Stimuleaz\u0103 echilibrul hormonal<\/p>\n<p><strong>CJC-1295 cu DAC<\/strong> con\u021bine compus peptidic sintetic.<\/p>","protected":false},"featured_media":70944,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5470],"class_list":{"0":"post-68994","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-cjc-1295-with-dac","9":"first","10":"instock","11":"shipping-taxable","12":"purchasable","13":"product-type-variable","14":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/68994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=68994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/70944"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=68994"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=68994"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=68994"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=68994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}